← All indications
Brain Injuries, Traumatic
A form of acquired brain injury which occurs when a sudden trauma causes damage to the brain.
Subtype terms (3)
More specific conditions that are subtypes of Brain Injuries, Traumatic in the MeSH hierarchy.
- Brain Concussion
39 drugs (26 approved, 13 experimental)
- Brain Contusion
3 drugs (2 approved, 1 experimental)
- Chronic Traumatic Encephalopathy
8 drugs (4 approved, 4 experimental)
Drugs by status
Approved for this indication (1)
Phase 4 trials (41)
- mannitol
- diclofenac
- melatonin
- phenobarbital
- propofol
- methylprednisolone
- buspirone
- porcine brain-derived peptide preparation
- astragalus membranaceus
- ketamine
- cisatracurium
- citalopram
- doxycycline
- methylphenidate
- valproic acid
- fosphenytoin
- somatropin
- l-glutamine
- insulin human
- amantadine
- esketamine
- levetiracetam
- topiramate
- memantine
- acetaminophen
- lidocaine
- propranolol
- quinidine
- rivastigmine
- acetylsalicylic acid
- +11 more
Phase 3 trials (33)
- ringer's lactate
- urea
- epoetin
- biperiden
- dextran
- progesterone
- egg
- cannabidiol
- gabapentin
- sertraline
- cobalamin
- rimabotulinumtoxinB
- niacin
- nitric oxide
- magnesium sulfate
- donepezil
- cannabis
- thiopental
- vortioxetine
- whole blood
- incobotulinumtoxinA
- l-epigallocatechin
- propanolol
- tranexamic acid
- oxygen
- blood plasma
- pentobarbital
- dalteparin
- armodafinil
- dexamethasone
- +3 more
Phase 2 trials (69)
- pbr28
- fddnp
- florbetapir
- acetylcysteine
- darbepoetin alfa
- procaine benzylpenicillin
- beta-hydroxybutyrate
- candesartan
- carbon dioxide
- norepinephrine
- cimicifuga
- C1 Esterase Inhibitor (Human)
- conjugated equine estrogens
- esmolol
- cycloserine
- duloxetine
- galantamine
- escitalopram
- glyburide
- dolutegravir
- bone marrow derived mesenchymal stem cells
- fibrinogen (human)
- icosapent ethyl
- baricitinib
- indocyanine green
- jnj-17299425
- motexafin gadolinium
- perfluoro tert-butylcyclohexane
- bromocriptine
- perfluorocarbon
- +39 more
Phase 1 trials (20)
Other trials (29)
- simvastatin
- levofloxacin
- ibuprofen
- efaproxiral
- ferrous fumarate
- palmitoylethanolamide
- isoflurane
- haloperidol
- carbamazepine
- leucine
- oligofructose-enriched inulin
- aluminum hydroxide
- pravastatin
- catecholamine
- sufentanil
- cellulose
- zoledronic acid
- umbilical cord mesenchymal stem cells
- valine
- atomoxetine
- modafinil
- multivitamins
- high oleic safflower
- vasopressin
- reserpine
- remifentanil
- fish oil
- branched chain amino acids
- oryza sativa
Organizations
Organization Involved with Phase 4 Indications (64)
- Shire
- Fresenius
- Forest Laboratories
- Aventis
- Pfizer
- Avanir
- Novartis
- Ever Neuro Pharma GmbH
- Hamad Medical Corporation
- Sponsor GmbH
- Kessler Foundation
- Ontario Neurotrauma Foundation
- Swiss National Science Foundation
- National Center for Research Resources (NCRR)
- University of Roma La Sapienza
- Shahid Beheshti University of Medical Sciences
- University of Pittsburgh
- Central South University
- Ain Shams University
- University of London
- Craig Hospital
- Damanhour University
- Harvard University
- Lancaster General Hospital
- Lianyungang Oriental Hospital
- Loewenstein Hospital
- Mansoura University
- Loyola University
- Methodist Rehabilitation Center
- Michigan State University
- +34 more
Organization Involved with Phase 3 Indications (81)
- Pharmos
- Takeda
- Cephalon
- Ipsen
- Cristália Produtos Químicos Farmacêuticos Ltda.
- INC Research
- Merz
- Vasopharm GmbH
- National Institutes of Health (NIH)
- Canadian Department of National Defense
- Direction Centrale du Service de Santé des Armées
- National Heart, Lung, and Blood Institute (NHLBI)
- National Institute of Neurological Disorders and Stroke (NINDS)
- United States Army
- University College Dublin
- Baylor University
- Cairo University
- Emory University
- Temple University
- University of Washington
- Hospital Son Espases
- Hospital Universitari Son Dureta
- Indiana University
- JFK Medical Center
- Johns Hopkins University
- Lund University
- Medical College of Wisconsin
- Medical University Innsbruck
- Monash University
- University of Maryland
- +51 more
Organization Involved with Phase 2 Indications (65)
- INTRuST
- Abbott
- Avid Radiopharmaceuticals
- Amgen
- AstraZeneca
- Novo Nordisk
- Eli Lilly
- Neuren Pharmaceuticals Limited
- NeuroHealing Pharmaceuticals Inc.
- Remedy Pharmaceuticals, Inc.
- SanBio, Inc.
- Tenax Therapeutics, Inc.
- National Institute of Nursing Research (NINR)
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- Uniformed Services University of the Health Sciences
- University of Pennsylvania
- University of Arizona
- American Heart Association
- Boston University
- Cedars-Sinai Medical Center
- Chang Gung University
- Dartmouth University
- HCA International Limited
- HonorHealth Research Institute
- Hoosier Cancer Research Network
- Mashhad University of Medical Sciences
- Mclean Hospital
- New York University
- Oregon Health and Science University
- Rehabilitation Hospital of Indiana
- +35 more
Organization Involved with Phase 1 Indications (26)
- Bioquark Inc.
- Molecular NeuroImaging
- Teva
- Transition Therapeutics
- Children's Medical Center Dallas
- Cornell University
- Institute for Neurodegenerative Disorders
- Minia University
- Neurogen Brain and Spine Institute
- University of Florida
- University of New Mexico
- University of Virginia
- Umea University
- Revita Life Sciences
- University of Montreal
- Lakeland Regional Medical Center
- University of Texas, San Antonio
- Anupam Hospital
- Texas Scottish Rite Hospital for Children
- Harch Hyperbaric Research Foundation
- Semper Fi Fund
- United States Marine Corps
- Coalition to Support America's Heroes
- Government of Egypt
- People's Liberation Army of China
- Pinteon Therapeutics, Inc
Organization Involved with Other Experimental Indications (23)
- Amen Clinics, Inc.
- Hamilton Health Sciences Corporation
- International Atomic Energy Agency
- United States Air Force
- United States Navy
- Allegiance Health
- Katholieke Universiteit Leuven
- Ohio State University
- Sheffield Hallam University
- Thomas Jefferson University
- University of Medicine and Dentistry of New Jersey
- University of Messina
- University of California, Berkeley
- Icahn School of Medicine at Mount Sinai
- Kessler Institute for Rehabilitation
- Harborview Injury Prevention and Research Center
- Padjadjaran University
- Cha Medical University
- Technion University
- The Defense and Veterans Brain Injury Center
- Rotherham Doncaster and South Humber NHS Foundation Trust
- The Institute for Rehabilitation and Research (TIRR) Foundation
- Gaymar Industries, Inc.